CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2.11B, above the global median of $1.18B
- FinancialsAltman Z-Score 5.31: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.40%
Annual Rate
CNY 0.43Paid annual
Payout Ratio
46.7%Sustainable
Payback Period
42.2 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
14.12BCNY2.11B · vs all stocks (USD)
Trailing P/E
19.75xRevenue (TTM)
6.13BCNY915.03M · vs all stocks (USD)
Profit Margin
11.53%Beta
0.1840xvs all stocks
52-Week Change
12.28%vs all stocks
Market Capitalization
14.12BCNY2.11B · vs all stocks (USD)
Enterprise Value
12.54BCNY1.87B · vs all stocks (USD)
Trailing P/E
19.75xPrice to Sales (TTM)
2.32xPrice to Book (MRQ)
1.67xEnterprise to Revenue
2.05xEnterprise to EBITDA
9.62xGross Margin
24.44%Profit Margin
11.53%Operating Margin
12.65%Return on Assets (TTM)
4.60%Return on Equity (TTM)
8.56%Revenue (TTM)
6.13BCNY915.03M · vs all stocks (USD)
Revenue per Share (TTM)
7.94CNYUpdated Sep 22, 2026Quarterly Revenue Growth
2.20%Gross Profit (TTM)
1.46BCNY218.39M · vs all stocks (USD)
EBITDA (TTM)
874.81MCNY130.63M · vs all stocks (USD)
Net Income (TTM)
706.60MCNY105.52M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-24.90%Operating Cash Flow (TTM)
911.35MCNY136.09M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
515.37MCNY76.96M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.4286CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
2.40%vs all stocks
Payout Ratio
46.73%Minority Interest (Equity)
2.43MCNYFY2025 · Dec 31, 2025Revenue
6.01BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.45BCNYFY2025 · Dec 31, 2025Gross Profit
1.56BCNYFY2025 · Dec 31, 2025Operating Income
961.88MCNY143.64M · vs all stocks (USD)
Pre-tax Income
951.26MCNYFY2025 · Dec 31, 2025Income Tax Expense
133.69MCNYFY2025 · Dec 31, 2025Net Income
817.57MCNYFY2025 · Dec 31, 2025EBIT
975.18MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.45BCNYFY2025 · Dec 31, 2025Research & Development
209.83MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
138.71MCNYFY2025 · Dec 31, 2025Other Operating Expenses
57.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
17.57MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
23.92MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.48CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.48CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
554.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
554.61MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
817.57MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.25MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
653.24MCNYFY2025 · Dec 31, 2025Free Cash Flow
399.63MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.12BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
817.57MCNYFY2025 · Dec 31, 2025Other Non-cash Items
24.96MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
258.28MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-447.57MCNYFY2025 · Dec 31, 2025Capital Expenditures
-253.61MCNYFY2025 · Dec 31, 2025Purchase of Investments
-15.97BCNYFY2025 · Dec 31, 2025Sale of Investments
15.37BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-851.46MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.03BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-813.79MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-359.63MCNYFY2025 · Dec 31, 2025Other Financing Charges
18.44MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-122.95MCNYFY2025 · Dec 31, 2025Shares Outstanding
782.35MSharesUpdated Sep 22, 2026Float Shares
313.04MSharesUpdated Sep 22, 2026% Held by Insiders
63.51%vs all stocks
% Held by Institutions
4.16%vs all stocks
Total Cash (MRQ)
2.51BCNY375.48M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.26CNYUpdated Sep 22, 2026Total Debt (MRQ)
1.03BCNY153.38M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1223xCurrent Ratio (MRQ)
2.33xBook Value per Share (MRQ)
10.88CNYUpdated Sep 22, 2026Total Assets
10.98BCNY1.64B · vs all stocks (USD)
Total Current Assets
6.11BCNYFY2025 · Dec 31, 2025Total Liabilities
2.43BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.87BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
507.82MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.92BCNYFY2025 · Dec 31, 2025Cash
1.34BCNYFY2025 · Dec 31, 2025Cash Equivalents
122.13MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.46BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.24BCNYFY2025 · Dec 31, 2025Accounts Receivable
859.33MCNYFY2025 · Dec 31, 2025Inventory
1.78BCNYFY2025 · Dec 31, 2025Accounts Payable
1.20BCNYFY2025 · Dec 31, 2025Short-term Debt
513.39MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.54MCNYFY2025 · Dec 31, 2025Long-term Debt
478.01MCNYFY2025 · Dec 31, 2025Common Stock (Book)
558.82MCNYFY2025 · Dec 31, 2025Retained Earnings
4.13BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.56BCNY1.28B · vs all stocks (USD)
52-Week Low
14.34CNYUpdated Sep 22, 202652-Week High
21.41CNYUpdated Sep 22, 202652-Week Change
12.28%vs all stocks
Beta
0.1840xvs all stocks
50-Day MA
15.91CNYUpdated Sep 22, 2026200-Day MA
17.20CNYUpdated Sep 22, 2026Avg 10-Day Volume
12.17MSharesUpdated Sep 22, 2026Avg 30-Day Volume
7.61MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.9200CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.31: safe zoneNotable
Altman Z-Score: 5.31
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2.11B, above the global median of $1.18BNotable
Market cap (USD): 2,108,758,975.028Global Median: 1,180,223,658.953
Revenue is $915.03M, above the global median of $548.88MNotable
Revenue (USD): 915,025,887.478Global Median: 548,883,780.48
Levered free cash flow is $76.96M, above the global median of $18.73MNotable
Levered free cash flow (USD): 76,959,956.004Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Wuhan Healthgen Biotechnology Corp.
Tier 1ProductionApproval-Gated PipelineRule
Pell Bio-Med Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Adma Biologics Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangzhong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ocular Therapeutix Inc.
Tier 1ProductionApproval-Gated PipelineRule
Bausch Health Companies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Granules India Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ab&B Bio-Tech Co., Ltd. (JS)
Tier 1ProductionApproval-Gated PipelineRule
Vericel Corporation
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Tapdi Oksijen Özel Sağlik Hizmetleri A.Ş.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
China World Trade Center Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
WuXi AppTec Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities